1 completed. .
Follow Alirocumab 150 mg: new trials by email Literature Review of Alirocumab 150 mg trials Research Report on Alirocumab 150 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine Clinical Practice Alirocumab 150 mg, Inclisiran - Atherosclerotic Cardiovascular Disease | Completed | Sanofi | 996 | 2025-05-22 | 2026-10-13 |
Atherosclerosis (1)
Sanofi (1)
United States (1)